Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability. (1st February 2018)

• Record Type: Journal Article
• Authors: Yang, Rujie; Li, Yingchao; Li, Jing; Liu, Cuiru; Du, Ping; Zhang, Tianhong
• Is Part Of: Drug development and industrial pharmacy. Volume 44:Number 2(2018)
• Page Start: 289
• Page End: 295
• Publication Date: 2018-02-01
• Subjects: Supercritical fluid -- coenzyme Q10 -- solid dispersion -- dissolution -- oral bioavailability; Pharmaceutical chemistry -- Periodicals; Pharmaceutical industry -- Periodicals; Drug Industry -- Periodicals; Technology, Pharmaceutical -- Periodicals; 615.05
• DOI: 10.1080/03639045.2017.1391833
• Languages: English
• ISSNs: 0363-9045

Abstract

Abstract: Objective: In this study, solid dispersion (SD) for oral delivery of a poorly water-soluble drug, coenzyme Q10 was developed by supercritical fluid technology and characterized in vitro and in vivo . Methods: Dissolution was used to optimize the formulations of CoQ10-SD. The physicochemical properties of SD were investigated by differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and scanning electron microscopy (SEM). The supercritical fluid chromatography–electrospray ionization tandem mass spectrometry (SFC–ESI-MS/MS) was used for the in vivo study. Results: The results of DSC and PXRD indicated that the drug in SD was in amorphous state. In vitro drug release, the dissolution of coenzyme Q10 in solid dispersion improved to 78.8% compared with commercial tablets of 0.16%. The area under c – t curve (AUC0–72h ) and mean maximum concentrations ( C max ) of CoQ10-SD were 2.43-fold and 3.0-fold, respectively higher than that of commercial tablets in rats, confirming improved bioavailability. Conclusion: Supercritical fluid technology was successfully used for the preparation and analysis of CoQ10-SD for the first time and significantly improved the dissolution and bioavailability of coenzyme Q10.